BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4724007)

  • 1. [A method of treating conjunctivitis sicca and Sjögren's disease with a secretolytic].
    Grosse-Ruyken FJ
    Klin Monbl Augenheilkd; 1973 Apr; 162(4):540-3. PubMed ID: 4724007
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new treatment for reduced tear production].
    Tiburtius H; Merker HJ
    Klin Monbl Augenheilkd; 1973 Apr; 162(4):535-9. PubMed ID: 4724006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of keratoconjunctivitis sicca using bromhexine-containing eye drops and bromhexine capsules].
    Neubauer O
    Wien Med Wochenschr; 1973 Dec; 123(48):719-22. PubMed ID: 4752629
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of bromhexin on the functional deficiency of the lacrimal apparatus and the salivary glands in Sjogren's syndrome].
    Isager H; Frost-Larsen K; Manthorpe R; Westergaard L
    Med Monatsschr; 1977 Dec; 31(12):582-3. PubMed ID: 593225
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of physalaemine on lacrimal and salivary secretion in Sjögren's syndrome].
    Sala G; Cortellaro M; Ballabio CB
    Reumatismo; 1968; 20(5):594-6. PubMed ID: 5736354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of physalaemin in the treatment of Sjogren's disease].
    Tamborini A; Perrotta P
    Ann Ottalmol Clin Ocul; 1969 Dec; 95(12):945-60. PubMed ID: 5408524
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of lacrimal deficiencies. Mechanical devices.
    Doane MG
    Int Ophthalmol Clin; 1973; 13(1):239-44. PubMed ID: 4724260
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of topical Healon tears in the management of refractory dry-eye syndrome.
    DeLuise VP; Peterson WS
    Ann Ophthalmol; 1984 Sep; 16(9):823-4. PubMed ID: 6508097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptoms and clinical course of keratitis filiformis with special regard to Sjogren's syndrome].
    Gläser W; Pietruschka G
    Z Arztl Fortbild (Jena); 1971 Jul; 65(14):720-5. PubMed ID: 5164944
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-molecular weight sodium hyaluronate in the treatment of tear film changes and of dry eye].
    Bohm E; Rama P; Tallandini L; Leardini G; de Carli MA
    Ophtalmologie; 1988 Oct; 2(4):353-4. PubMed ID: 3247207
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eledoisin eyedrops in the therapy of keratoconjunctivitis sicca].
    Spinelli D; Trabucchi P; Formenti F
    Ophtalmologie; 1988; 2(2):145-7. PubMed ID: 3247153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Original therapeutic endeavor for the Gougerot-Sjögren syndrome].
    Bonnet M; Moulin J; Girod M; Gouillon L; Biard L
    Bull Soc Ophtalmol Fr; 1969; 69(5-6):615-22. PubMed ID: 5399676
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our experience with the treatment of ocular changes in Sjögren's syndrome].
    Portacha L
    Klin Oczna; 1984 Nov; 86(11):485-6. PubMed ID: 6535881
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of sodium sucrose-sulfate on the ocular surface of patients with keratoconjunctivitis sicca in Sjögren's syndrome.
    Prause JU; Bjerrum K; Johansen S
    Adv Exp Med Biol; 1994; 350():691-6. PubMed ID: 8030557
    [No Abstract]   [Full Text] [Related]  

  • 19. [Piroxicam eyedrops in keratoconjunctivitis sicca. A new therapeutic perspective].
    Bragliani G; Franco F; Marescotti A; Gaiba G
    Ophtalmologie; 1988 Oct; 2(4):359-62. PubMed ID: 3247209
    [No Abstract]   [Full Text] [Related]  

  • 20. [Initial experience using protease inhibitors in treating Sjögren's disease and syndrome].
    Matveĭkov GP; Soroka NF; Paliĭ LI
    Revmatologiia (Mosk); 1985; (3):50-3. PubMed ID: 3903933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.